Lupin Unit Sues Ranbaxy Again Over Generic Antara
A Lupin Ltd. unit on Thursday fired another volley in Pennsylvania federal court against Ranbaxy Laboratories Ltd. over a generic version of Antara, following a new patent issued on the cholesterol-lowering...To view the full article, register now.
Already a subscriber? Click here to view full article